We are live on ! Find out more
NBP

NovaBridge Biosciences American Depositary Shares
NBP

136 hedge funds and large institutions have $2.38B invested in NovaBridge Biosciences American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 71 funds opening new positions, 32 increasing their positions, 22 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

23,455% more call options, than puts

Call options by funds: $1.26B | Put options by funds: $5.36M

407% more first-time investments, than exits

New positions opened: 71 | Existing positions closed: 14

110% more capital invested

Capital invested by funds: $1.13B → $2.38B (+$1.25B)

70% more funds holding

Funds holding: 80 → 136 (+56)

56% more funds holding in top 10

Funds holding in top 10: 9 → 14 (+5)

45% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 22

1.9% more ownership

Funds ownership: 14.09% → 15.99% (+1.9%)

Holders
136
Holders Change
+56
Holders Change %
+70%
% of All Funds
2.37%
Holding in Top 10
14
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+55.56%
% of All Funds
0.24%
New
71
Increased
32
Reduced
22
Closed
14
Calls
$1.26B
Puts
$5.36M
Net Calls
+$1.26B
Net Calls Change
+$1.26B

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$108M
2
ZAM
Zeal Asset Management
Hong Kong
+$65.2M
3
Temasek Holdings
Temasek Holdings
Singapore
+$40M
4
Principal Financial Group
Principal Financial Group
Iowa
+$31.5M
5
State Street
State Street
Massachusetts
+$28M

Top Sellers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
-$39.6M
2
Artisan Partners
Artisan Partners
Wisconsin
-$27.3M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$25.8M
4
GCM
Ghisallo Capital Management
Massachusetts
-$20.4M
5
Millennium Management
Millennium Management
New York
-$20.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
KFA
76
Krane Funds Advisors
New York
$1.65M +$1.28M +19,433 +9,668%
Citigroup
77
Citigroup
New York
$1.63M -$833K -12,622 -39%
SSA
78
Schonfeld Strategic Advisors
New York
$1.6M -$3.37M -51,151 -73%
Jane Street
79
Jane Street
New York
$1.5M +$1.18M +17,866 New
PPA
80
Parametric Portfolio Associates
Washington
$1.26M +$993K +15,059 New
Los Angeles Capital Management
81
Los Angeles Capital Management
California
$1.26M +$994K +15,060 New
Zurich Cantonal Bank
82
Zurich Cantonal Bank
Switzerland
$1.14M +$817K +12,389 +1,078%
BCIM
83
British Columbia Investment Management
British Columbia, Canada
$1.13M +$891K +13,500 New
NSRI
84
New Silk Road Investment
Singapore
$1.01M – – –
Susquehanna International Group
85
Susquehanna International Group
Pennsylvania
$922K +$725K +10,985 New
AllianceBernstein
86
AllianceBernstein
Tennessee
$909K +$714K +10,822 New
ICM
87
Infini Capital Management
Hong Kong
$840K +$660K +10,000 New
IMF
88
Infini Master Fund
Hong Kong
$840K +$660K +10,000 New
Aviva
89
Aviva
United Kingdom
$806K +$633K +9,600 New
SFI
90
Susquehanna Fundamental Investments
Pennsylvania
$801K – – –
Citadel Advisors
91
Citadel Advisors
Florida
$775K +$269K +4,084 +79%
Asset Management One
92
Asset Management One
Japan
$747K +$588K +8,910 New
GCP
93
GSA Capital Partners
United Kingdom
$733K +$576K +8,731 New
EFMH
94
E Fund Management (HK)
Hong Kong
$694K +$545K +8,266 New
Squarepoint
95
Squarepoint
New York
$680K +$534K +8,100 New
Mitsubishi UFJ Asset Management
96
Mitsubishi UFJ Asset Management
Japan
$655K +$515K +7,800 New
DekaBank Deutsche Girozentrale
97
DekaBank Deutsche Girozentrale
Germany
$552K +$139K +2,104 +44%
SEI Investments
98
SEI Investments
Pennsylvania
$527K +$414K +6,282 New
IBT
99
International Biotechnology Trust
United Kingdom
$503K -$1.91M -29,000 -83%
ProShare Advisors
100
ProShare Advisors
Maryland
$481K +$378K +5,735 New
2 3
4
5 6

NBP Hedge Fund Activity: Q2 2021 in Review

136 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q2 2021, worth a combined $2.38B — up 110% from $1.13B a quarter earlier.

Buyers outnumbered sellers: 71 funds opened new NBP positions and 14 closed out — a net gain of 57 holders — while 32 added to existing stakes and 22 trimmed.

The largest buyer was BlackRock, adding an estimated $108M. The largest seller was Avidity Partners Management, cutting an estimated $39.6M.

  • 136 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q2 2021, up from 80 in Q1 2021.
  • Funds reported $2.38B of NovaBridge Biosciences American Depositary Shares stock for Q2 2021, up 110% quarter-over-quarter.
  • 71 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q2 2021 and 14 closed out, a net change of +57 holders.
  • The largest NovaBridge Biosciences American Depositary Shares buyer in Q2 2021 was BlackRock, an estimated $108M added.
  • The largest NovaBridge Biosciences American Depositary Shares seller in Q2 2021 was Avidity Partners Management, an estimated $39.6M sold.

Based on aggregated 13F filings for Q2 2021.